New wearable detects fatigue accurately using AI and advanced sensors

Burnout and chronic fatigue carry a substantial economic cost and pose serious risks in professions where alertness is critical. Yet diagnosing fatigue and related mental health conditions today relies largely on self-reported questionnaires, which tend to be subjective, intermittent and poorly suited to real-time evaluation. Wearable devices could fill the gap by continuously tracking cardiovascular … Read more

Study finds higher heart disease risk in long COVID patients

People with long COVID are at increased risk of developing cardiovascular disease, according to a new study from Karolinska Institutet published in eClinicalMedicine. The results show that the risk of conditions such as cardiac arrhythmias and coronary artery disease is higher even among those who were not hospitalized during the acute infection. Long COVID has … Read more

Digital twin hearts improve outcomes in arrhythmia ablation procedures

Working with “digital twins” of patients’ hearts, doctors improved cardiac ablation outcomes for patients with life-threatening arrythmias. In the first clinical trials for cardiac digital twins technology, researchers at Johns Hopkins University created digital replicas of patients’ hearts, then tested procedures on those twins before performing them on the real thing. Working with digital twins … Read more

Imaging study measures pancreatic fat in children and teens

Higher fat content in the pancreas of children and adolescents with obesity is associated with an increased level of heart and metabolic risk factors, including higher than average body mass index (BMI), elevated diastolic blood pressure, higher levels of abdominal and liver fat, and insulin resistance, according to new research presented at this year’s European … Read more

Early treatment helps patient recover from rare kidney disorder

When Bradley Lawrence gained 25 pounds in two weeks and started experiencing chest pain and shortness of breath, he quickly sought care at NYU Langone Hospital—Brooklyn. He was soon diagnosed with nephrotic syndrome, a rare kidney disorder that can cause permanent damage if left untreated. Five months later, Lawrence is now in remission and has … Read more

How gut imbalance may drive obesity, diabetes, and heart disease

A sweeping new review shows how disruptions in the gut microbiome may fuel obesity, insulin resistance, and cardiovascular risk, while pointing to diet and other microbiome-focused strategies that could help restore metabolic balance. Integrative mechanistic framework linking gut dysbiosis to systemic metabolic dysfunction. Arrows indicate the progression of events from exogenous and host-related factors to … Read more

Measuring heart fat with AI improves cardiovascular risk prediction

Mayo Clinic research identified a powerful new way to improve the prediction of a patient’s long-term cardiovascular disease risk by enhancing a routinely performed imaging test with artificial intelligence (AI). Heart disease develops over time and remains the leading cause of death worldwide, so identifying risk early is critical to preventing heart attack, stroke and other serious outcomes. … Read more

Irregular bedtime could double the risk of serious cardiac events

An irregular bedtime in midlife may signal an increased risk of cardiovascular disease. A new study from the University of Oulu suggests that large swings in when people go to bed could double the risk of serious cardiac events—particularly among those who get less than eight hours of sleep. The researchers found that inconsistent bedtimes … Read more

AI eye exams accurately identify heart disease risk during routine visits

A new system that uses artificial intelligence (AI) to assess cardiovascular risk based on images of the eye captured during eye exams demonstrated strong correlation with a standard cardiovascular risk assessment, according to a study presented at the American College of Cardiology’s Annual Scientific Session (ACC.26). Researchers said using AI to screen for heart disease … Read more

Triglyceride-lowering drug olezarsen fails to reduce arterial plaque

Despite experiencing significant reductions in triglycerides, patients with triglycerides over 150 mg/dL and a high risk of atherosclerosis did not experience any significant change in the amount of non-calcified plaque in their coronary arteries after taking the triglyceride-lowering drug olezarsen, in a one-year sub-study presented at the American College of Cardiology’s Annual Scientific Session (ACC.26). … Read more